Fulgent Genetics (FLGT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Fulgent Genetics (FLGT) is Neutral.

The composite score behind that read is +0.06, weighing +0.15 of bullish evidence against -0.15 bearish.

Fulgent Genetics last closed at $21.74, +4.42% on the session.

Against the IVW growth benchmark the position is +3.62% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

Fulgent Genetics has no graded predictions yet. We publish our accuracy across thousands of stocks in the open, misses included.

On the fundamentals StockMap ranks Fulgent Genetics in the 33rd percentile on return on equity, where 100 is best.

Fulgent Genetics is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $572.86M.

StockMap tracks Fulgent Genetics as the 60th largest of the 85 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 81 Neutral and 4 Moderate Underperform.

On that composite Fulgent Genetics ranks 20th of 85 in the group, against a group median of +0.00.